Results 251 to 260 of about 1,082,836 (299)
Some of the next articles are maybe not open access.
Annual Review of Microbiology, 1980
INTRODUCTION ......... .. ..... ..... ..... .. ... ....... 49 The Killer Character 50 The killing reaction ....... ..... 51 Other killer systems .. ......... ......... ..... ...... ...... 51 ScVas a model system 52 PHYSICAL PROPERTIES OF ScV PARTICLES 52 CAPSID POLYPEPTIDES ........ 55 ScV RNAs 56 Structure .. .
openaire +2 more sources
INTRODUCTION ......... .. ..... ..... ..... .. ... ....... 49 The Killer Character 50 The killing reaction ....... ..... 51 Other killer systems .. ......... ......... ..... ...... ...... 51 ScVas a model system 52 PHYSICAL PROPERTIES OF ScV PARTICLES 52 CAPSID POLYPEPTIDES ........ 55 ScV RNAs 56 Structure .. .
openaire +2 more sources
Virus-like particles in human milk
Cancer, 1971Human milk from 59 women was studied by electron microscopy for the presence of viruslike particles. 2 types of viruslike particles were seen: 1) a small particle 20-40 mM and 2) a larger particle closely resembling the murine oncogenic ribonucleic acid virus.
W F, Feller, H C, Chopra
openaire +2 more sources
Transcutaneous vaccination with virus-like particles
Vaccine, 2006Virus-like particles (VLP) are inert, empty capsids of viruses, which contain no DNA/RNA from the virus itself. However they retain the structure of a virus and they can be engineered to have antigens attached. We have constructed VLP, derived from Rabbit hemorrhagic disease virus, and shown they are highly immunogenic.
Young, Sarah +5 more
openaire +3 more sources
Meningoencephalitis with toroidal virus-like particles
Acta Neuropathologica, 1975A previously healthy middle aged man died following a 6 month illness which presented with middle ear symptoms, apparently resolved, and then 2 months later manifested as encephalitis. The illness was characterized initially by depression and intellectual deterioration. No family member or working associate was affected. The clinical diagnosis of viral
H C, Powell, A I, Braude, P W, Lampert
openaire +2 more sources
Virus-Like Particles as Particulate Vaccines
Current HIV Research, 2010Particulate structures hold great promise for the development of effective and affordable recombinant prophylactic as well as therapeutic vaccines. Different types of particulate structures, including virus-like particles (VLPs) and virosomes, have been developed depending on the nature of the viral pathogen to be targeted and the type of immune ...
Luigi, Buonaguro +2 more
openaire +2 more sources
Virus-Like Particles in Rheumatoid Synovium
Scandinavian Journal of Rheumatology, 1973The synovial membrane of 42 rheumatoid patients was investigated by electron microscope. In the whole material particles were found possessing a fibro-granular core and an outer envelope of 1200-2 200 A diameter in the majority. These particles were mainly demonstrated in the cytoplasm of endothelial cells, fibroblasts and lymphoid cells. In some cases
T, Neumark, I, Hollós, K, Farkas
openaire +2 more sources
Engineered virus-like nanoparticle heparin antagonists
2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2013Virus nanoparticles provide a self-assembling, reproducible multivalent platform that can be chemically and genetically manipulated for the presentation of a wide array of epitopes. Presented herein are engineered bacteriophage Qβ nanoparticles that function as potent heparin antagonists.
openaire +2 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly